trial · primary record
OPGx-RDH12
Leber Congenital Amaurosis
| Phase | Phase 1, Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 10 |
| Primary completion | 2034-07 |
| Primary endpoint | Number of dose-limiting toxicity (DLT) events at the proposed doses |
| Registry ID | NCT07681778 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T03:27:48.330Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07681778
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.